Hyderabad Telangana, India

Ponnampalli Swapna

This inventor holds 3 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2014-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ponnampalli Swapna. Retrieved from https://idiyas.com/inventor/ponnampalli-swapna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 7.7

ph-index = 1


Company Filing History:


Years Active: 2014-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ponnampalli Swapna: Innovator in Anti-Tubercular Research

Introduction

Ponnampalli Swapna is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of potential anti-tubercular agents. With a total of 3 patents to his name, Swapna is recognized for his innovative research and dedication to improving public health.

Latest Patents

His latest patents include the synthesis of new benzothiazole derivatives, which are disclosed as compounds of general formula A. These compounds are being explored for their potential as anti-tubercular agents. The present disclosure emphasizes the utility of these compounds in combating tuberculosis, a disease that continues to pose a significant health challenge globally.

Career Highlights

Ponnampalli Swapna is affiliated with the Council of Scientific & Industrial Research, where he conducts his research. His work is characterized by a commitment to scientific excellence and innovation. His contributions have been instrumental in advancing the understanding of anti-tubercular compounds.

Collaborations

Some of his notable coworkers include Ahmed Kamal and Rajesh Vcrnc Shetti. Their collaborative efforts have further enhanced the research output and innovation in their field.

Conclusion

Ponnampalli Swapna's work in the synthesis of anti-tubercular agents showcases his dedication to addressing critical health issues. His innovative research continues to pave the way for new therapeutic options in the fight against tuberculosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…